Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology.

Lamani M, Malamas MS, Farah SI, Shukla VG, Almeida MF, Weerts CM, Anderson J, Wood JT, Farizatto KLG, Bahr BA, Makriyannis A.

Bioorg Med Chem. 2019 Dec 1;27(23):115096. doi: 10.1016/j.bmc.2019.115096. Epub 2019 Sep 10.

PMID:
31629610
2.

Endocannabinoid Metabolome Characterization of Milk from Guatemalan Women Living in the Western Highlands.

Gaitán AV, Wood JT, Solomons NW, Donohue JA, Ji L, Liu Y, Nikas SP, Zhang F, Allen LH, Makriyannis A, Lammi-Keefe CJ.

Curr Dev Nutr. 2019 Mar 27;3(6):nzz018. doi: 10.1093/cdn/nzz018. eCollection 2019 Jun.

3.

Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward.

Sagheddu C, Scherma M, Congiu M, Fadda P, Carta G, Banni S, Wood JT, Makriyannis A, Malamas MS, Pistis M.

Neuropharmacology. 2019 Jan;144:327-336. doi: 10.1016/j.neuropharm.2018.11.013. Epub 2018 Nov 12.

PMID:
30439418
4.

Endocannabinoid Metabolome Characterization of Transitional and Mature Human Milk.

Gaitán AV, Wood JT, Zhang F, Makriyannis A, Lammi-Keefe CJ.

Nutrients. 2018 Sep 12;10(9). pii: E1294. doi: 10.3390/nu10091294.

5.

( R)- N-(1-Methyl-2-hydroxyethyl)-13-( S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes.

Liu Y, Ji L, Eno M, Kudalkar S, Li AL, Schimpgen M, Benchama O, Morales P, Xu S, Hurst D, Wu S, Mohammad KA, Wood JT, Zvonok N, Papahatjis DP, Zhou H, Honrao C, Mackie K, Reggio P, Hohmann AG, Marnett LJ, Makriyannis A, Nikas SP.

J Med Chem. 2018 Oct 11;61(19):8639-8657. doi: 10.1021/acs.jmedchem.8b00611. Epub 2018 Sep 21.

PMID:
30196704
6.

Oximes short-acting CB1 receptor agonists.

Malamas MS, Raghav JG, Ma X, Honrao C, Wood JT, Benchama O, Zhou H, Mallipeddi S, Makriyannis A.

Bioorg Med Chem. 2018 Oct 1;26(18):4963-4970. doi: 10.1016/j.bmc.2018.08.003. Epub 2018 Aug 2.

PMID:
30122284
7.

A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models.

Parker LA, Limebeer CL, Rock EM, Sticht MA, Ward J, Turvey G, Benchama O, Rajarshi G, Wood JT, Alapafuja SO, Makriyannis A.

Psychopharmacology (Berl). 2016 Jun;233(12):2265-75. doi: 10.1007/s00213-016-4277-y. Epub 2016 Apr 6.

8.

"Rolled-upness": phenotyping leaf rolling in cereals using computer vision and functional data analysis approaches.

Sirault XR, Condon AG, Wood JT, Farquhar GD, Rebetzke GJ.

Plant Methods. 2015 Nov 14;11:52. doi: 10.1186/s13007-015-0095-1. eCollection 2015.

9.

Correction to an orally active phenylaminotetralin-chemotype serotonin 5-HT7 and 5-HT1A receptor partial agonist that corrects motor stereotypy in mouse models.

Canal CE, Felsing DE, Liu Y, Zhu W, Wood JT, Perry CK, Vemula R, Booth RG.

ACS Chem Neurosci. 2015 Aug 19;6(8):1486. doi: 10.1021/acschemneuro.5b00197. Epub 2015 Jul 30. No abstract available.

PMID:
26225542
10.

An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse Models.

Canal CE, Felsing DE, Liu Y, Zhu W, Wood JT, Perry CK, Vemula R, Booth RG.

ACS Chem Neurosci. 2015 Jul 15;6(7):1259-70. doi: 10.1021/acschemneuro.5b00099. Epub 2015 Jun 8. Erratum in: ACS Chem Neurosci. 2015 Aug 19;6(8):1486.

PMID:
26011730
11.

Diet-induced changes in n-3- and n-6-derived endocannabinoids and reductions in headache pain and psychological distress.

Ramsden CE, Zamora D, Makriyannis A, Wood JT, Mann JD, Faurot KR, MacIntosh BA, Majchrzak-Hong SF, Gross JR, Courville AB, Davis JM, Hibbeln JR.

J Pain. 2015 Aug;16(8):707-16. doi: 10.1016/j.jpain.2015.04.007. Epub 2015 May 7.

12.

Interactive effects of fire and large herbivores on web-building spiders.

Foster CN, Barton PS, Wood JT, Lindenmayer DB.

Oecologia. 2015 Sep;179(1):237-48. doi: 10.1007/s00442-015-3323-5. Epub 2015 May 3.

PMID:
25935217
13.

AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.

Keenan CM, Storr MA, Thakur GA, Wood JT, Wager-Miller J, Straiker A, Eno MR, Nikas SP, Bashashati M, Hu H, Mackie K, Makriyannis A, Sharkey KA.

Br J Pharmacol. 2015 May;172(9):2406-18. doi: 10.1111/bph.13069. Epub 2015 Feb 27.

14.

Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinols.

Nikas SP, Sharma R, Paronis CA, Kulkarni S, Thakur GA, Hurst D, Wood JT, Gifford RS, Rajarshi G, Liu Y, Raghav JG, Guo JJ, Järbe TU, Reggio PH, Bergman J, Makriyannis A.

J Med Chem. 2015 Jan 22;58(2):665-81. doi: 10.1021/jm501165d. Epub 2014 Dec 16.

15.

C-ring cannabinoid lactones: a novel cannabinergic chemotype.

Sharma R, Nikas SP, Guo JJ, Mallipeddi S, Wood JT, Makriyannis A.

ACS Med Chem Lett. 2014 Jan 14;5(4):400-4. doi: 10.1021/ml4005304. eCollection 2014 Apr 10.

16.

Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study.

Fichna J, Wood JT, Papanastasiou M, Vadivel SK, Oprocha P, Sałaga M, Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Małecka-Panas E, Krajewska WM, Kościelniak P, Makriyannis A, Storr MA.

PLoS One. 2013 Dec 27;8(12):e85073. doi: 10.1371/journal.pone.0085073. eCollection 2013.

17.

Controlled-deactivation cannabinergic ligands.

Sharma R, Nikas SP, Paronis CA, Wood JT, Halikhedkar A, Guo JJ, Thakur GA, Kulkarni S, Benchama O, Raghav JG, Gifford RS, Järbe TU, Bergman J, Makriyannis A.

J Med Chem. 2013 Dec 27;56(24):10142-57. doi: 10.1021/jm4016075. Epub 2013 Dec 10.

18.

Using invasion process theory to enhance the understanding and management of introduced species: a case study reconstructing the invasion sequence of the common myna (Acridotheres tristis).

Grarock K, Lindenmayer DB, Wood JT, Tidemann CR.

J Environ Manage. 2013 Nov 15;129:398-409. doi: 10.1016/j.jenvman.2013.08.005. Epub 2013 Aug 29.

PMID:
23995141
19.

Does human-induced habitat modification influence the impact of introduced species? A case study on cavity-nesting by the introduced common myna (Acridotheres tristis) and two Australian native parrots.

Grarock K, Lindenmayer DB, Wood JT, Tidemann CR.

Environ Manage. 2013 Oct;52(4):958-70. doi: 10.1007/s00267-013-0088-7. Epub 2013 May 29.

PMID:
23716011
20.

The effects of winter recreation on alpine and subalpine fauna: a systematic review and meta-analysis.

Sato CF, Wood JT, Lindenmayer DB.

PLoS One. 2013 May 15;8(5):e64282. doi: 10.1371/journal.pone.0064282. Print 2013. Review.

21.

Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054.

McLaughlin PJ, Thakur GA, Vemuri VK, McClure ED, Brown CM, Winston KM, Wood JT, Makriyannis A, Salamone JD.

Pharmacol Biochem Behav. 2013 Aug;109:16-22. doi: 10.1016/j.pbb.2013.04.011. Epub 2013 Apr 19.

22.

Antitrypanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth.

Andriani G, Amata E, Beatty J, Clements Z, Coffey BJ, Courtemanche G, Devine W, Erath J, Juda CE, Wawrzak Z, Wood JT, Lepesheva GI, Rodriguez A, Pollastri MP.

J Med Chem. 2013 Mar 28;56(6):2556-67. doi: 10.1021/jm400012e. Epub 2013 Mar 13.

23.

Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.

Li H, Wood JT, Whitten KM, Vadivel SK, Seng S, Makriyannis A, Avraham HK.

Br J Pharmacol. 2013 Oct;170(3):489-505. doi: 10.1111/bph.12111.

24.

Can individual and social patterns of resource use buffer animal populations against resource decline?

Banks SC, Lindenmayer DB, Wood JT, McBurney L, Blair D, Blyton MD.

PLoS One. 2013;8(1):e53672. doi: 10.1371/journal.pone.0053672. Epub 2013 Jan 8.

25.

Therapeutic modulation of cannabinoid lipid signaling: metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist.

Wood JT, Smith DM, Janero DR, Zvonok AM, Makriyannis A.

Life Sci. 2013 Mar 19;92(8-9):482-91. doi: 10.1016/j.lfs.2012.06.019. Epub 2012 Jun 28.

26.

Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology.

Naidoo V, Karanian DA, Vadivel SK, Locklear JR, Wood JT, Nasr M, Quizon PM, Graves EE, Shukla V, Makriyannis A, Bahr BA.

Neurotherapeutics. 2012 Oct;9(4):801-13. doi: 10.1007/s13311-011-0100-y.

27.

Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase.

West JM, Zvonok N, Whitten KM, Wood JT, Makriyannis A.

J Proteome Res. 2012 Feb 3;11(2):972-81. doi: 10.1021/pr200735a. Epub 2012 Jan 3.

28.

Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.

Bashashati M, Storr MA, Nikas SP, Wood JT, Godlewski G, Liu J, Ho W, Keenan CM, Zhang H, Alapafuja SO, Cravatt BF, Lutz B, Mackie K, Kunos G, Patel KD, Makriyannis A, Davison JS, Sharkey KA.

Br J Pharmacol. 2012 Mar;165(5):1556-71. doi: 10.1111/j.1476-5381.2011.01644.x.

29.

The enigmatic genome of Chara australis virus.

Gibbs AJ, Torronen M, Mackenzie AM, Wood JT, Armstrong JS, Kondo H, Tamada T, Keese PL.

J Gen Virol. 2011 Nov;92(Pt 11):2679-2690. doi: 10.1099/vir.0.033852-0. Epub 2011 Jul 6.

PMID:
21733884
30.

Foliage chemistry influences tree choice and landscape use of a gliding marsupial folivore.

Youngentob KN, Wallis IR, Lindenmayer DB, Wood JT, Pope ML, Foley WJ.

J Chem Ecol. 2011 Jan;37(1):71-84. doi: 10.1007/s10886-010-9889-9. Epub 2010 Dec 16.

PMID:
21161340
31.

A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity.

Naidoo V, Nikas SP, Karanian DA, Hwang J, Zhao J, Wood JT, Alapafuja SO, Vadivel SK, Butler D, Makriyannis A, Bahr BA.

J Mol Neurosci. 2011 Mar;43(3):493-502. doi: 10.1007/s12031-010-9472-4. Epub 2010 Nov 11.

32.

The neutral cannabinoid CB₁ receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat.

Cluny NL, Chambers AP, Vemuri VK, Wood JT, Eller LK, Freni C, Reimer RA, Makriyannis A, Sharkey KA.

Pharmacol Biochem Behav. 2011 Jan;97(3):537-43. doi: 10.1016/j.pbb.2010.10.013. Epub 2010 Nov 4.

33.

A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents.

Cluny NL, Vemuri VK, Chambers AP, Limebeer CL, Bedard H, Wood JT, Lutz B, Zimmer A, Parker LA, Makriyannis A, Sharkey KA.

Br J Pharmacol. 2010 Oct;161(3):629-42. doi: 10.1111/j.1476-5381.2010.00908.x.

34.

Heteroadamantyl cannabinoids.

Dixon DD, Sethumadhavan D, Benneche T, Banaag AR, Tius MA, Thakur GA, Bowman A, Wood JT, Makriyannis A.

J Med Chem. 2010 Aug 12;53(15):5656-66. doi: 10.1021/jm100390h.

35.

Evolutionary dynamics of the N1 neuraminidases of the main lineages of influenza A viruses.

Fourment M, Wood JT, Gibbs AJ, Gibbs MJ.

Mol Phylogenet Evol. 2010 Aug;56(2):526-35. doi: 10.1016/j.ympev.2010.04.039. Epub 2010 Apr 29.

PMID:
20434570
36.

Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma.

Wood JT, Williams JS, Pandarinathan L, Janero DR, Lammi-Keefe CJ, Makriyannis A.

J Lipid Res. 2010 Jun;51(6):1416-23. doi: 10.1194/jlr.M002436. Epub 2010 Jan 13.

37.

Memantine binding to a superficial site on NMDA receptors contributes to partial trapping.

Kotermanski SE, Wood JT, Johnson JW.

J Physiol. 2009 Oct 1;587(Pt 19):4589-604. doi: 10.1113/jphysiol.2009.176297. Epub 2009 Aug 17.

38.

Testing hypotheses associated with bird responses to wildfire.

Lindenmayer DB, Wood JT, Cunningham RB, MacGregor C, Crane M, Michael D, Montague-Drake R, Brown D, Muntz R, Gill AM.

Ecol Appl. 2008 Dec;18(8):1967-83.

PMID:
19263891
39.

The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats.

Prus AJ, Pehrson AL, Philibin SD, Wood JT, Vunck SA, Porter JH.

Psychopharmacology (Berl). 2009 Apr;203(2):295-301. doi: 10.1007/s00213-008-1262-0. Epub 2008 Aug 7.

PMID:
18685832
40.

Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.

Järbe TU, LeMay BJ, Olszewska T, Vemuri VK, Wood JT, Makriyannis A.

Pharmacol Biochem Behav. 2008 Nov;91(1):84-90. doi: 10.1016/j.pbb.2008.06.014. Epub 2008 Jun 29.

41.

Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters.

Wood JT, Williams JS, Pandarinathan L, Courville A, Keplinger MR, Janero DR, Vouros P, Makriyannis A, Lammi-Keefe CJ.

Clin Chem Lab Med. 2008;46(9):1289-95. doi: 10.1515/CCLM.2008.242.

42.

Lateralization of visual learning in the honeybee.

Letzkus P, Boeddeker N, Wood JT, Zhang SW, Srinivasan MV.

Biol Lett. 2008 Feb 23;4(1):16-8.

43.

A neutral CB1 receptor antagonist reduces weight gain in rat.

Chambers AP, Vemuri VK, Peng Y, Wood JT, Olszewska T, Pittman QJ, Makriyannis A, Sharkey KA.

Am J Physiol Regul Integr Comp Physiol. 2007 Dec;293(6):R2185-93. Epub 2007 Oct 24.

44.

Conformationally constrained analogues of 2-arachidonoylglycerol.

Vadivel SK, Vardarajan S, Duclos RI Jr, Wood JT, Guo J, Makriyannis A.

Bioorg Med Chem Lett. 2007 Nov 1;17(21):5959-63. Epub 2007 Aug 21.

45.

Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage.

Karanian DA, Karim SL, Wood JT, Williams JS, Lin S, Makriyannis A, Bahr BA.

J Pharmacol Exp Ther. 2007 Sep;322(3):1059-66. Epub 2007 Jun 1.

PMID:
17545313
46.

Patterns of recombination in turnip mosaic virus genomic sequences indicate hotspots of recombination.

Ohshima K, Tomitaka Y, Wood JT, Minematsu Y, Kajiyama H, Tomimura K, Gibbs AJ.

J Gen Virol. 2007 Jan;88(Pt 1):298-315.

PMID:
17170463
47.

The variable codons of H3 influenza A virus haemagglutinin genes.

Gibbs MJ, Wayper P, Fourment ML, Wood JT, Ohshima K, Armstrong JS, Gibbs AJ.

Arch Virol. 2007 Jan;152(1):11-24. Epub 2006 Sep 8.

PMID:
16957828
48.

Lateralization of olfaction in the honeybee Apis mellifera.

Letzkus P, Ribi WA, Wood JT, Zhu H, Zhang SW, Srinivasan MV.

Curr Biol. 2006 Jul 25;16(14):1471-6.

49.

Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387.

McLaughlin PJ, Qian L, Wood JT, Wisniecki A, Winston KM, Swezey LA, Ishiwari K, Betz AJ, Pandarinathan L, Xu W, Makriyannis A, Salamone JD.

Pharmacol Biochem Behav. 2006 Mar;83(3):396-402. Epub 2006 Mar 6.

PMID:
16616951
50.

Marker-based quantitative genetics in the wild?: the heritability and genetic correlation of chemical defenses in eucalyptus.

Andrew RL, Peakall R, Wallis IR, Wood JT, Knight EJ, Foley WJ.

Genetics. 2005 Dec;171(4):1989-98. Epub 2005 Sep 2.

Supplemental Content

Support Center